Israel - English - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - chewable tablets - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.because the benefits of singulair may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.

Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 250 mg/tablet - amoxicillin and enzyme inhibitor - dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 50 mg/tablet - amoxicillin and enzyme inhibitor - cats, dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 500 mg/tablet - amoxicillin and enzyme inhibitor - dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 62.5 mg/tablet - amoxicillin and enzyme inhibitor - cats, dogs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - amoxicillin; clavulanic acid - chewable tablet - 625 mg/tablet - amoxicillin and enzyme inhibitor - dogs - antibacterial